Study Title: Anti-Coronavirus Therapies to prevent COVID-19 progression (ACT) Trial
SRHC Principal Investigator: Dr. Carter Thorne
Summary: The goal of this study is to test whether certain drugs can prevent disease progression. The drugs being tested are hydroxychloroquine or chloroquine, which are commonly used to treat malaria, rheumatoid arthritis or lupus; azithromycin, which is an antibiotic that is used to treat bacterial infections and interferon beta, which is commonly used to treat multiple sclerosis.
Study Population: COVID-19 positive inpatients and outpatients
Study Title: Assessing the psychological, social, and economic impacts of an emerging pandemic (C19 Online Survey)
SRHC Principal Investigator: Janet Jeffrey, RN, PhD
Summary: To examine the psychological, social, and economic impacts of the COVID-19 pandemic at various stages of the outbreak. Special attention will be given to social isolation, as well as family and work related factors.
Study Population: All individuals who are at least 12 years of age
Link to Survey: COVID-19 Online Survey
Study Title: Risk of death or respiratory failure in patients with COVID-19 who received an ACE inhibitor, ARB, or NSAID: A Multicentre Cohort study [COVID-ACE/ARB/NSAID]
SRHC Principal Investigator: Dr. Yaariv Khayin
Summary: A retrospective study investigating the association between use of ACE inhibitors, ARBs, or NSAIDs with all-cause mortality, intensive care unit (ICU) admission or respiratory failure requiring mechanical ventilation among hospitalized patients with a confirmed diagnosis of COVID-19.
Study Population: COVID-19 positive adults 40 years and older